Using ultrasound to treat recurrent thyroid cancer
Official title: Ultrasound-guided Thermal Ablation for Recurrent Thyroid Cancer: A Multicenter Study
Run by Chinese PLA General Hospital · NCT06733766 · Data updated 2026-11-12
This study is testing if using ultrasound to heat and destroy recurrent thyroid cancer can be a safe and effective treatment for patients who have already had surgery for their thyroid cancer.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 300 (estimated) |
| Sponsor | Chinese PLA General Hospital Academic / other |
| Locations | 1 site (Beijing, Beijing Municipality) |
| Status | Recruiting |
| Started | December 9, 2024 |
| Main results expected | December 31, 2028 |
| Study ends | December 31, 2030 |
| Registry record updated | February 14, 2025 |
| Trial ID | NCT06733766 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are patients who have had a thyroidectomy for thyroid cancer and have pathologically confirmed recurrent lesions without distant metastases.
✕Probably not a fit
Patients with coagulation disorders or serious organ failures, as well as those with vocal cord dysfunction on the opposite side, may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study evaluates the long-term outcomes of ultrasound-guided thermal ablation in patients with recurrent thyroid cancer. It is a multicenter observational study that aims to predict the effectiveness and safety of this treatment approach. Patients who have previously undergone thyroidectomy and have confirmed recurrent lesions will be monitored over a follow-up period of at least 12 months to assess their outcomes.
Why it matters
Potential benefit: If successful, this treatment could provide a less invasive option for managing recurrent thyroid cancer, potentially improving patient outcomes.
How similar studies have gone: Other studies have shown promising results with ultrasound-guided thermal ablation for similar conditions, indicating potential for success in this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. patient received thyroidectomy for thyroid cancer 2. recurrent lesions were pathologically proven to be malignant by core-needle biopsy or fine needle aspiration 3. no evidence of distant metastases. 4. follow-up period ≥12 months Exclusion Criteria: 1. coagulation disorder, serious heart, respiratory, liver, or renal failure 2. dysfunction of the vocal cord on the opposite side
Where it's running
-
Chinese PLA General Hospital
Beijing, Beijing Municipality, China Recruiting
Study contacts
- Principal investigator: Yukun Luo — Chinese PLA General Hospital
- Study coordinator: Lin Yan
- Email: gemma-y@163.com
- Phone: 13811237313
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Combining radiotherapy and radioactive iodine for thyroid cancer treatment
This study is testing whether combining radioactive iodine and external beam radiotherapy can safely improve treatment for people with recurrent thyroid cancer that has spread and can't be fully removed.
-
CD19 and CD22 in vivo CAR-T therapy for relapsed/refractory B-ALL
This study tests a one-of-a-kind in vivo CAR-T treatment that targets CD19 first and then CD22 in adults with relapsed or refractory B-ALL to see if it is safe and possibly effective.
-
Romiplostim to help platelets grow after donor stem cell transplant
This phase II trial tests whether weekly romiplostim helps patients over 18 who receive a haploidentical or fully matched unrelated donor stem cell transplant to engraft platelets faster than best supportive care.
-
Exercise effect on the lumbar multifidus in back pain
This study tests whether a 12-week home rehab program can change ultrasound features of the lumbar multifidus and reduce pain in adults with chronic non-specific low back pain from multifidus injury.
-
Can preoperative photon-counting CT help predict heart recovery after bypass surgery?
This observational study tests whether a preoperative photon-counting CT can help predict heart function 3 months after coronary bypass surgery in adults with coronary artery disease.
-
BEX101 CAR-T at the bedside for relapsed or refractory B-cell NHL
A bedside, on-site CAR-T therapy called BEX101 is being tested in adults with relapsed or refractory B-cell non-Hodgkin’s lymphoma to see if it is safe and can help control the disease.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.